Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines.
Livi L, Meattini I, Scotti V, De Luca Cardillo C, Galardi A, Iermano C, Sanchez L, Nori J, Mangoni M, Franzese C, Orzalesi L, Bertocci S, Agresti B, Masoni T, Bianchi S, Cataliotti L, Biti G. Livi L, et al. Among authors: sanchez l. J Chemother. 2011 Jun;23(3):158-62. doi: 10.1179/joc.2011.23.3.158. J Chemother. 2011. PMID: 21742585
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.
Meattini I, Saieva C, Meacci F, Scotti V, De Luca Cardillo C, Desideri I, Baldazzi V, Mangoni M, Scoccianti S, Detti B, Simontacchi G, Nori J, Orzalesi L, Sanchez L, Casella D, Bernini M, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: sanchez l. Future Oncol. 2016 Mar;12(5):625-35. doi: 10.2217/fon.15.357. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26837239
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.
Meattini I, Desideri I, Di Cataldo V, Francolini G, De Luca Cardillo C, Scotti V, Loi M, Detti B, Mangoni M, Agresti B, Baldazzi V, Greto D, Casella D, Bernini M, Sanchez LJ, Orzalesi L, Nori J, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: sanchez lj. Future Oncol. 2016 May;12(9):1117-24. doi: 10.2217/fon-2015-0059. Epub 2016 Mar 9. Future Oncol. 2016. PMID: 26956105
Postmastectomy radiotherapy in breast cancer adjuvant treatment.
Livi L, Meattini I, Di Cataldo V, Cardillo Cde L, Scotti V, Sanchez L, Nori J, Agresti B, Iermano C, Pasquetti EM, Bianchi S, Cataliotti L, Biti G. Livi L, et al. Among authors: sanchez l. Minerva Chir. 2010 Oct;65(5):527-36. Minerva Chir. 2010. PMID: 21081864 Review.
Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
Meattini I, Livi L, Franceschini D, Saieva C, Meacci F, Marrazzo L, Bendinelli B, Scotti V, De Luca Cardillo C, Nori J, Sanchez L, Orzalesi L, Bonomo P, Greto D, Bucciolini M, Bianchi S, Biti G. Meattini I, et al. Among authors: sanchez l. Eur J Surg Oncol. 2013 Jun;39(6):613-8. doi: 10.1016/j.ejso.2013.03.002. Epub 2013 Mar 20. Eur J Surg Oncol. 2013. PMID: 23523088
Breast cancer in the elderly: treatment of 1500 patients.
Livi L, Paiar F, Saieva C, Simontacchi G, Nori J, Sanchez L, Santini R, Mangoni M, Fondelli S, Distante V, Bianchi S, Biti G. Livi L, et al. Among authors: sanchez l. Breast J. 2006 Jul-Aug;12(4):353-9. doi: 10.1111/j.1075-122X.2006.00275.x. Breast J. 2006. PMID: 16848846
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.
Livi L, Meattini I, Saieva C, Franzese C, Di Cataldo V, Greto D, Franceschini D, Scotti V, Bonomo P, Nori J, Sanchez L, Vezzosi V, Bianchi S, Cataliotti L, Biti G. Livi L, et al. Among authors: sanchez l. Cancer. 2012 Jul 1;118(13):3236-43. doi: 10.1002/cncr.26647. Epub 2011 Oct 25. Cancer. 2012. PMID: 22028054 Free article.
2,324 results